FMR LLC reports 1.9% stake in Nuvalent
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
FMR LLC filed Amendment No. 5 to Schedule 13G/A disclosing beneficial ownership of 1,417,590.47 shares of Nuvalent Inc. Class A common stock, representing 1.9% of the class as reported with CUSIP 670703107 and a reporting reference date of 06/30/2026. The filing shows sole voting power of 1,402,750 and sole dispositive power of 1,417,590.47 shares, and is signed on behalf of FMR LLC and Abigail P. Johnson.
Insights
FMR reports a modest passive stake of 1.9% in Nuvalent as a Schedule 13G/A amendment.
FMR LLC's filing lists 1,417,590.47 shares beneficially owned with sole dispositive power; the disclosure is administrative and consistent with passive institutional reporting under Schedule 13G/A. The filing references an exhibit for a 13d-1(k) agreement.
Because the stake is under 5%, this remains a non‑control passive holding. Subsequent filings or exhibits may provide further detail on any subsidiary holding structure or voting arrangements.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficial ownership financial
Sole dispositive power regulatory
13d-1(k) agreement regulatory
Exhibit 99 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Nuvalent's Class A stock does FMR LLC hold?
Who signed the Schedule 13G/A amendment for FMR LLC?
Where can I find more detail about the holding or subsidiary structure?
AI-generated analysis. How Rhea-AI works. Not financial advice.